Alison Bladh

DECEMBER 3, 2024

The Sweet Superfood: Health Benefits of Dates for Women Over 40 Dates, often called "nature's candy," have been enjoyed for centuries as a delicious and nutrient-packed fruit. For women over 40, dates are an excellent way to boost energy, support digestive health, and promote overall well-being. Packed with essential vitamins, minerals, and fibre, they’re a simple addition to your diet that can make a big impact on your health.

Diet 102

Diet Technology Management 102

Beautiful With Brains - Ingredients

DECEMBER 3, 2024

Is silica in skincare safe? Word on the beauty streets is that silica is trying to kill you. Silica is the latest ingredient accused of giving you silicosis and all sorts of nasty diseases. Once the rumours start, everyone adds its fair share of gossip and side effects. We don’t do gossip here. We do […] The post Is Silica in Skincare Dangerous?

Skincare 90

Skincare Ingredients 90

Dermatology Times

DECEMBER 3, 2024

LOV has unique clinical traits, epidemiology, and treatment responses compared to early-onset vitiligo, underscoring the need for a tailored management approach.

Clinic 73

Clinic Management Treatments 73

Beauty Launchpad

DECEMBER 3, 2024

Per Adobe Analytics, "57% of online sales came through a mobile device on Cyber Monday," a gain of 13.3%, year-over-year.

Sales 52

Sales 52

Dermatology Times

DECEMBER 3, 2024

Explore key insights and innovations in vitiligo from 2024, from treatment advances to patient-focused strategies.

Innovations 48

Innovations Treatments 48

Skin Inc

DECEMBER 3, 2024

When did we begin to fear aging? Journey with us, as we explore beauty's obsession with beating father time and explore how this conversation is starting to change.

Treatments 40

Treatments 40

The Dermatology Digest

DECEMBER 3, 2024

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization in Great Britain for delgocitinib cream (Anzupgo, Leo Pharma) for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. Delgocitinib cream is now the first approved topical pan-Janus kinase (JAK) inhibitor treatment specifically for adults with moderate to severe CHE in Great Britain.

Marketing 36

Marketing Eczema Safety Management 36

Dermatology Times

DECEMBER 3, 2024

Treatment with delgocitinib led to a significant decrease in the expression of inflammatory markers that were elevated in severe cases compared with mild cases at baseline.

Treatments 41

Treatments 41

The Dermatology Digest

DECEMBER 3, 2024

Johnson & Johnson submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of guselkumab (Tremfya) for the treatment of children 6 and older with moderate-to-severe plaque psoriasis (PsO) and children 5 and up with active juvenile psoriatic arthritis (jPsA). Guselkumab is the first approved monoclonal antibody that selectively binds to the p19 subunit of interleukin (IL)-23 and inhibits its interaction with the IL-23 re

Safety 41

Safety Innovations Dermatology Treatments 41

Dermatology Times

DECEMBER 3, 2024

Regenerative methods such as cell therapy and platelet-rich plasma showed promising results in patient repigmentation.

Treatments 37

Treatments Therapy 37

Dermatology Times

DECEMBER 3, 2024

Panelists discuss how atopic dermatitis impacts different demographic groups through variations in disease presentation, treatment access, and quality of life outcomes.

Dermatitis 36

Dermatitis Treatments 36

Dermatology Times

DECEMBER 3, 2024

Panelists discuss how atopic dermatitis significantly impacts patients' mental health, social relationships, and daily activities, creating substantial psychosocial burdens that can lead to anxiety, depression, and reduced quality of life.

Dermatitis 36

Dermatitis 36

Dermatology Times

DECEMBER 3, 2024

Panelists discuss how health care providers must balance the convenience and accessibility of telemedicine with individual patient needs and clinical considerations when delivering dermatological care.

Clinic 36

Clinic Dermatology 36